Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-ketonic hyperglycinemia].

B Cabalska1

  • 1Instytut Matki i Dziecka, Kasprzaka 17a, 01-211, Warszawa, Poland.

Medycyna Wieku Rozwojowego
|November 28, 2000
PubMed
Summary

Nonketotic hyperglycinemia (NKH) causes brain damage in infants. Diagnosis requires specific glycine levels and ratios, differentiating it from other hyperglycinemic states and organic acidurias. Treatment involves medications like sodium benzoate and dextromethorphan.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different presentations of late-detected phenylketonuria in two brothers with the same R408W/R111X genotype in the PAH gene.

Journal of intellectual disability research : JIDR·2003
Same author

Should newborn mutation scanning for hyperphenylalaninaemia and galactosaemia be implemented? A Polish experience.

Journal of medical screening·2001
Same author

[Standards for diagnosis and treatment of phenylketonuria].

Medycyna wieku rozwojowego·2001
Same author

[Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].

Medycyna wieku rozwojowego·2000
Same author

[Mutations causing hereditary hyperphenylalaninemia].

Medycyna wieku rozwojowego·2000
Same author

[Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience].

Medycyna wieku rozwojowego·2000

Area of Science:

  • Neurology
  • Biochemistry
  • Genetics

Context:

  • Nonketotic hyperglycinemia (NKH) is a severe metabolic disorder affecting newborns and infants.
  • Understanding the pathomechanism of brain damage in NKH is crucial for effective management.
  • Atypical presentations and characteristic EEG patterns in neonatal NKH require specialized diagnostic approaches.

Purpose:

  • To elucidate the pathomechanism and clinical course of severe, atypical nonketotic hyperglycinemia in newborns and infants.
  • To detail diagnostic methods, emphasizing glycine levels, CSF-to-serum ratios, and differentiation from other hyperglycinemic states.
  • To present current treatment strategies, including novel therapeutic combinations.

Summary:

  • This review discusses the brain damage mechanisms and clinical spectrum of severe, atypical nonketotic hyperglycinemia (NKH) in infants.
  • Diagnostic criteria include elevated blood and urine glycine, a high CSF-to-serum glycine ratio, and differentiation from organic acidurias via urinary organic acid analysis.
  • Prenatal diagnosis, molecular identification, and therapeutic options, including combined sodium benzoate and dextromethorphan, are presented.

Impact:

  • Provides a comprehensive overview for clinicians diagnosing and managing nonketotic hyperglycinemia.
  • Highlights the importance of accurate diagnostic differentiation to guide appropriate treatment.
  • Informs future research directions in understanding NKH pathogenesis and therapeutic development.

Related Experiment Videos